Immunovaccine in research pact with NRC
The collaboration aims to design a carbohydrate-based vaccine, using the DepoVax formulation, that can produce antibody levels specific to the carbohydrate target and capable of neutralizing meningococci. The
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.